Efficacy of DAAs in the Treatment of Chronic HCV: Real-World Data from the Private Health-Care Sector of the Kingdom of Saudi Arabia

• Үндсэн зохиолчид: Almoutaz Hashim (Зохиогч), Fadia Almahdi (Зохиогч), Emad Aldin Albaba (Зохиогч), Ohoud Barkia (Зохиогч), Reem Alkasam (Зохиогч), Asmaa Almahmoud (Зохиогч), Ahmed Nabil (Зохиогч), Ayman Alsulaimani (Зохиогч), Mahmoud Mosli (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Springer, 2020-02-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background and Aim: The hepatitis C virus (HCV) is considered a global health challenge that requires urgent interventions for prevention and control. In this study, we aimed to evaluate the effectiveness of direct-acting antiviral agents (DAAs) for HCV-infected patients in the Kingdom of Saudi Arab...